SS
NVO

SBI Securities’s Novo Nordisk NVO Stock Holding History

SBI Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Sell
27,582
-3,896
-12% -$167K 0.03% 245
2026
Q1 		$1.16M Buy
31,478
+5,979
+23% +$283K 0.03% 250
2025
Q4 		$1.3M Buy
25,499
+615
+2% +$31.4K 0.03% 238
2025
Q3 		$1.38M Buy
24,884
+10,548
+74% +$617K 0.04% 230
2025
Q2 		$989K Buy
14,336
+1,186
+9% +$80.7K 0.03% 268
2025
Q1 		$913K Buy
13,150
+1,354
+11% +$112K 0.03% 263
2024
Q4 		$1.01M Buy
+11,796
New +$1.28M 0.03% 244

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

SBI Securities's NVO Position: Q2 2026 in Review

SBI Securities reduced its Novo Nordisk (NVO) stake by 12% in Q2 2026, selling an estimated $167K and leaving 27,582 shares worth $1.32M. The position accounts for 0.03% of the portfolio, ranked #245.

SBI Securities first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.38M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • SBI Securities held 27,582 shares of Novo Nordisk worth $1.32M as of Q2 2026.
  • SBI Securities sold 3,896 Novo Nordisk shares in Q2 2026, an estimated $167K.
  • Novo Nordisk made up 0.03% of SBI Securities's portfolio in Q2 2026, its #245 holding.
  • SBI Securities first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Novo Nordisk position peaked at $1.38M in Q3 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.